These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2169060)

  • 41. Tumor necrosis factor receptor-mediated signaling pathways.
    Heller RA; Krönke M
    J Cell Biol; 1994 Jul; 126(1):5-9. PubMed ID: 8027185
    [No Abstract]   [Full Text] [Related]  

  • 42. Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases.
    Dinarello CA
    Curr Opin Immunol; 1991 Dec; 3(6):941-8. PubMed ID: 1665333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumour necrosis factor signal transduction.
    Krönke M; Schütze S; Scheurich P; Meichle A; Hensel G; Thoma B; Kruppa G; Pfizenmaier K
    Cell Signal; 1990; 2(1):1-8. PubMed ID: 2176798
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cytokines and receptors--their functions, structures and cloning of code genes. Lymphotoxins].
    Kasakura S
    Nihon Rinsho; 1988 May; 46(5):1036-40. PubMed ID: 3261810
    [No Abstract]   [Full Text] [Related]  

  • 45. Tumor necrosis factor: a master-regulator of leukocyte movement.
    Sedgwick JD; Riminton DS; Cyster JG; Körner H
    Immunol Today; 2000 Mar; 21(3):110-3. PubMed ID: 10689296
    [No Abstract]   [Full Text] [Related]  

  • 46. Tumor necrosis factor receptors--structure and function.
    Rothe J; Gehr G; Loetscher H; Lesslauer W
    Immunol Res; 1992; 11(2):81-90. PubMed ID: 1331273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some misconceptions about understanding autoimmunity through experiments with knockouts.
    Steinman L
    J Exp Med; 1997 Jun; 185(12):2039-41. PubMed ID: 9221283
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of TNF in diverse pathologic processes.
    Kunkel SL; Strieter RM; Chensue SW; Campbell DA; Remick DG
    Biotherapy; 1991; 3(2):135-41. PubMed ID: 2054254
    [No Abstract]   [Full Text] [Related]  

  • 49. Cytokine regulation of expression of class I MHC antigens.
    Raval A; Puri N; Rath PC; Saxena RK
    Exp Mol Med; 1998 Mar; 30(1):1-13. PubMed ID: 9873816
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytokines, receptors, and inhibitors.
    Gehr G; Braun T; Lesslauer W
    Clin Investig; 1992 Jan; 70(1):64-9. PubMed ID: 1318126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line.
    Meager A
    J Immunol Methods; 1991 Nov; 144(1):141-3. PubMed ID: 1960402
    [No Abstract]   [Full Text] [Related]  

  • 52. Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.
    Darnay BG; Aggarwal BB
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I2-I13. PubMed ID: 10577967
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute effects of tumor necrosis factor-alpha or lymphotoxin on oxygenation and bioenergetic status in experimental tumors.
    Engel T; Vaupel P
    Adv Exp Med Biol; 1994; 345():501-8. PubMed ID: 8079750
    [No Abstract]   [Full Text] [Related]  

  • 54. Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models.
    Ruuls SR; Sedgwick JD
    Am J Hum Genet; 1999 Aug; 65(2):294-301. PubMed ID: 10417271
    [No Abstract]   [Full Text] [Related]  

  • 55. Why is too little TNF bad?
    Bendtzen K
    Cytokine; 1991 Nov; 3(6):636-7. PubMed ID: 1790308
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular crosstalk. Will virology and growth-factor research aid cytokine drug discovery?
    Edgington SM
    Biotechnology (N Y); 1993 Apr; 11(4):465-7, 470. PubMed ID: 7764047
    [No Abstract]   [Full Text] [Related]  

  • 57. Tumor necrosis factor-alpha.
    Rock CS; Lowry SF
    J Surg Res; 1991 Nov; 51(5):434-45. PubMed ID: 1661798
    [No Abstract]   [Full Text] [Related]  

  • 58. Structure of tumor necrosis factor and its receptor.
    Aggarwal BB
    Biotherapy; 1991; 3(2):113-20. PubMed ID: 1647190
    [No Abstract]   [Full Text] [Related]  

  • 59. Tumour necrosis factors in clinical practice.
    Goh CR
    Ann Acad Med Singap; 1990 Mar; 19(2):235-9. PubMed ID: 2189343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The common mediator of shock, cachexia, and tumor necrosis.
    Beutler B; Cerami A
    Adv Immunol; 1988; 42():213-31. PubMed ID: 2834923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.